caffeine has been researched along with flufenamic acid in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 7 (41.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Breuiller, M; Cedard, L; Ferre, F | 1 |
Nelemans, FA | 1 |
Chen, S; Inoue, R; Ito, Y | 1 |
Guan, Z; Saqr, HE; Stokes, BT; Yates, AJ | 1 |
Kietzmann, M; Lehr, CM; Meiers, P; Netzlaff, F; Niedorf, F; Schaefer, UF; Stahl, J | 1 |
Bock, U; Diembeck, W; Düsing, HJ; Gamer, A; Haltner-Ukomadu, E; Hoffmann, C; Kaca, M; Kamp, H; Kersen, S; Kietzmann, M; Korting, HC; Krächter, HU; Lehr, CM; Liebsch, M; Mehling, A; Müller-Goymann, C; Netzlaff, F; Niedorf, F; Rübbelke, MK; Schäfer, U; Schäfer-Korting, M; Schmidt, E; Schreiber, S; Spielmann, H; Vuia, A; Weimer, M | 1 |
Bock, U; Haltner-Ukomadu, E; Harms, M; Hoffmann, C; Kaca, M; Lehr, CM; Müller-Goymann, C; Netzlaff, F; Schäfer, U; Tawfik Jalal, M | 1 |
Hansen, S; Heisig, M; Kostka, KH; Lehr, CM; Meiers, P; Naegel, A; Neumann, D; Schaefer, UF; Wittum, G | 1 |
Bastos-González, D; Lehr, CM; Loretz, B; Ortega-Vinuesa, JL; Santander-Ortega, MJ; Schaefer, UF; Stauner, T; Wenz, G | 1 |
Heisig, M; Naegel, A; Wittum, G | 1 |
Hahn, T; Kostka, KH; Lehr, CM; Neumann, D; Schaefer, UF; Selzer, D | 1 |
Hahn, T; Heisig, M; Kostka, KH; Lehr, CM; Naegel, A; Neumann, D; Schaefer, UF; Selzer, D; Wittum, G | 1 |
17 other study(ies) available for caffeine and flufenamic acid
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Human placental cAMP phosphodiesterase activity kinetic properties and sensitivity to some drugs and hormones.
Topics: Caffeine; Cyclic AMP; Epinephrine; Estradiol; Female; Flufenamic Acid; Hormones; Humans; Imidazoles; Indomethacin; Insulin; Kinetics; Magnesium; Norepinephrine; Pharmacology; Phosphoric Diester Hydrolases; Placenta; Pregnancy; Progesterone; Prostaglandins; Theophylline | 1975 |
[Analgesics in dentistry].
Topics: Acetanilides; Agranulocytosis; Analgesics; Anesthesia, Dental; Aspirin; Blood Coagulation; Caffeine; Codeine; Drug Combinations; Flufenamic Acid; Gastrointestinal Hemorrhage; Heterocyclic Compounds; Humans; Indomethacin; Mefenamic Acid; Morphinans; Mouth Diseases; ortho-Aminobenzoates; Phenacetin | 1972 |
Pharmacological characterization of muscarinic receptor-activated cation channels in guinea-pig ileum.
Topics: 4-Aminopyridine; Acetylcholine; Animals; Caffeine; Calcium Channels; Diphenylamine; Egtazic Acid; Electrophysiology; Female; Flufenamic Acid; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Ileum; In Vitro Techniques; Ion Channels; Male; Membrane Potentials; Muscle, Smooth; Nystatin; Procaine; Quinine; Receptors, Muscarinic; Tetraethylammonium Compounds | 1993 |
Mechanisms through which PDGF alters intracellular calcium levels in U-1242 MG human glioma cells.
Topics: Becaplermin; Brain Neoplasms; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Calcium-Transporting ATPases; Elapid Venoms; Endoplasmic Reticulum; Enzyme Inhibitors; Flufenamic Acid; Glioma; Humans; Imidazoles; Ion Transport; Masoprocol; Neoplasm Proteins; Nicardipine; Nimodipine; Nitrendipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Peptides; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Ryanodine; Thapsigargin; Tumor Cells, Cultured; Verapamil | 1999 |
Comparison of bovine udder skin with human and porcine skin in percutaneous permeation experiments.
Topics: Animals; Benzoic Acid; Caffeine; Cattle; Flufenamic Acid; Humans; In Vitro Techniques; Models, Biological; Permeability; Skin; Skin Absorption; Swine; Testosterone | 2006 |
The use of reconstructed human epidermis for skin absorption testing: Results of the validation study.
Topics: Animal Testing Alternatives; Animals; Caffeine; Epidermis; Flufenamic Acid; Humans; Ivermectin; Mannitol; Organ Culture Techniques; Plastic Surgery Procedures; Reproducibility of Results; Skin Absorption; Skin Irritancy Tests; Swine | 2008 |
The physicochemical parameters of marker compounds and vehicles for use in in vitro percutaneous absorption studies.
Topics: Animal Testing Alternatives; Animals; Benzoic Acid; Buffers; Caffeine; Clotrimazole; Culture Media; Digoxin; Epidermis; Flufenamic Acid; Germany; Humans; Micelles; Polyethylene Glycols; Skin Absorption | 2008 |
The role of corneocytes in skin transport revised--a combined computational and experimental approach.
Topics: Biological Transport; Caffeine; Epidermal Cells; Epidermis; Female; Flufenamic Acid; Humans; Keratins; Lipids; Models, Biological; Protein Binding; Skin Absorption; Solubility; Testosterone; Water | 2009 |
Nanoparticles made from novel starch derivatives for transdermal drug delivery.
Topics: Administration, Cutaneous; Buffers; Caco-2 Cells; Caffeine; Cell Survival; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Drug Stability; Female; Flufenamic Acid; Humans; In Vitro Techniques; Nanoparticles; Pharmaceutical Preparations; Skin; Skin Absorption; Solubility; Solvents; Starch; Testosterone | 2010 |
Computational modeling of the skin barrier.
Topics: Biological Transport; Caffeine; Cell Shape; Cell Size; Computer Simulation; Diffusion; Flufenamic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Lipids; Membranes, Artificial; Models, Theoretical; Permeability; Skin; Skin Absorption; Solubility; Water | 2011 |
Influence of the application area on finite dose permeation in relation to drug type applied.
Topics: Administration, Cutaneous; Caffeine; Flufenamic Acid; Humans; Permeability; Skin; Skin Absorption | 2012 |
Finite dose skin mass balance including the lateral part: comparison between experiment, pharmacokinetic modeling and diffusion models.
Topics: Caffeine; Diffusion; Female; Flufenamic Acid; Humans; Models, Biological; Skin; Skin Absorption | 2013 |